Ashby Iype
Psychiatry · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Ashby Iype’s office at (408) 792-2100 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Drugs they prescribed that Part D paid
$162,111
Pharmacies billed $162,111 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,450) in 2024. At or below the middle of the specialty; the typical psychiatry & neurology clinician is at 0%.
1,391 generic and 59 brand-name prescriptions · $162,111 in drug cost · 240 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Invega Sustenna | 20 | $40,735 | $2,037 |
| Clozapine | 93 | $5,030 | $54 |
| Fluphenazine Decanoate | 31 | $2,043 | $66 |
| Olanzapine | 64 | $1,917 | $30 |
| Quetiapine | 108 | $1,896 | $18 |
See all 33 drugs
| Invega Sustenna | 20 | $40,735 | $2,037 |
| Clozapine | 93 | $5,030 | $54 |
| Fluphenazine Decanoate | 31 | $2,043 | $66 |
| Olanzapine | 64 | $1,917 | $30 |
| Quetiapine | 108 | $1,896 | $18 |
| Ziprasidone | 24 | $1,548 | $65 |
| Divalproex Sodium Er | 61 | $1,301 | $21 |
| Risperidone | 150 | $1,279 | $9 |
| Benztropine Mesylate | 56 | $784 | $14 |
| Haloperidol | 19 | $641 | $34 |
| Quetiapine Fumarate Er | 26 | $544 | $21 |
| Haloperidol Decanoate | 23 | $467 | $20 |
| Aripiprazole | 39 | $423 | $11 |
| Hydroxyzine | 40 | $420 | $10 |
| Bupropion Hcl Sr | 30 | $415 | $14 |
| Sertraline | 81 | $366 | $5 |
| Fluoxetine | 81 | $346 | $4 |
| Trazodone | 54 | $259 | $5 |
| Buspirone | 39 | $252 | $6 |
| Bupropion Xl | 38 | $251 | $7 |
| Prazosin | 19 | $240 | $13 |
| Trihexyphenidyl | 46 | $233 | $5 |
| Lurasidone | 13 | $222 | $17 |
| Paroxetine | 23 | $218 | $9 |
| Guanfacine | 11 | $206 | $19 |
| Gabapentin | 25 | $190 | $8 |
| Propranolol | 15 | $151 | $10 |
| Duloxetine | 19 | $146 | $8 |
| Lithium Carbonate | 38 | $142 | $4 |
| Lamotrigine | 18 | $123 | $7 |
| Divalproex | 12 | $113 | $9 |
| Mirtazapine | 16 | $95 | $6 |
| Clonazepam | 22 | $77 | $3 |
Year by year
| 2024 | 1,450 | 98 | 0% (0) | 4% | $162,111 |
| 2023 | 88 | 27 | 0% (0) | None | $11,216 |
| 2022 | 288 | 43 | 0% (0) | None | $18,972 |
| 2021 | 163 | 36 | 0% (0) | None | $8,069 |
| 2020 | 91 | 32 | 0% (0) | None | $6,424 |
| 2019 | 21 | 15 | 0% (0) | None | $655 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Clozapine | 12 | $925 | $77 |
2022: 11 drugs
| Duloxetine | 40 | $1,041 | $26 |
| Bupropion Xl | 19 | $688 | $36 |
| Aripiprazole | 18 | $553 | $31 |
| Trazodone | 30 | $510 | $17 |
| Gabapentin | 12 | $502 | $42 |
| Venlafaxine Hcl Er | 11 | $411 | $37 |
| Hydroxyzine | 21 | $375 | $18 |
| Fluoxetine | 19 | $341 | $18 |
| Escitalopram | 12 | $221 | $18 |
| Buspirone | 11 | $205 | $19 |
| Sertraline | 15 | $119 | $8 |
2021: 4 drugs
| Aripiprazole | 17 | $994 | $58 |
| Bupropion Xl | 11 | $601 | $55 |
| Duloxetine | 27 | $581 | $22 |
| Trazodone | 12 | $120 | $10 |
Money from drug and device companies
$1,040 in 2025
| 2025 | 5 | 9 | None | $1,040 |
| 2024 | 3 | 3 | None | $388 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Invega Sustenna | $365 | 3 payments
|
| Neurocrine BioSciences | Ingrezza | $276 | 2 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $203 | 2 payments
|
| Neuronetics | Neurostar Tms Therapy System | $165 | 1 payment
|
| Otsuka America Pharmaceutical | Abilify Asimtufii | $31 | 1 payment
|
See all 9 published payments
| Teva Pharmaceuticals USA | Meals · 2025-09-30 | Austedo Xr | $84 |
| Neurocrine BioSciences | Meals · 2025-09-16 | Ingrezza | $139 |
| Janssen Pharmaceuticals | Meals · 2025-09-04 | Invega Sustenna | $111 |
| Teva Pharmaceuticals USA | Meals · 2025-08-28 | Austedo Xr | $118 |
| Janssen Pharmaceuticals | Meals · 2025-07-31 | Invega Sustenna | $104 |
| Janssen Pharmaceuticals | Meals · 2025-06-18 | Invega Sustenna | $149 |
| Neuronetics | Meals · 2025-05-23 | Neurostar Tms Therapy System | $165 |
| Otsuka America Pharmaceutical | Meals · 2025-05-19 | Abilify Asimtufii | $31 |
| Neurocrine BioSciences | Meals · 2025-01-28 | Ingrezza | $138 |
See earlier years (2024)
2024: $388
| Neurocrine Biosciences | Ingrezza | $139 | 1 payment
|
| Otsuka America Pharmaceutical | Abilify Maintena | $125 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $125 | 1 payment
|
Professional record
- NPI
- 1346700804
- Licence
- FL TRN28694
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 828 S Bascom Ave Ste 200, San Jose, CA, 95128
- NPI first listed
- 2019-03-21
- NPI last updated
- 2026-02-23
- NPI record certified
- 2026-02-23
This is when the NPI record was last certified, not a medical board exam.